TWST Twist Bioscience Corp

Price (delayed)

$39.64

Market cap

$2.29B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.61

Enterprise value

$2.12B

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of ...

Highlights
TWST's revenue is up by 22% YoY and by 7% from the previous quarter
TWST's EPS is up by 6% year-on-year
TWST's quick ratio is down by 8% year-on-year but it is up by 2.3% since the previous quarter
Twist Bioscience's equity has decreased by 21% YoY and by 5% QoQ
TWST's gross margin is down by 18% year-on-year and by 2.2% since the previous quarter

Key stats

What are the main financial stats of TWST
Market
Shares outstanding
57.82M
Market cap
$2.29B
Enterprise value
$2.12B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.87
Price to sales (P/S)
8.69
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.07
Earnings
Revenue
$262.36M
EBIT
-$204.6M
EBITDA
-$169.85M
Free cash flow
-$128.84M
Per share
EPS
-$3.61
Free cash flow per share
-$2.24
Book value per share
$10.23
Revenue per share
$4.56
TBVPS
$10.33
Balance sheet
Total assets
$732.82M
Total liabilities
$142.77M
Debt
$91.88M
Equity
$590.04M
Working capital
$325M
Liquidity
Debt to equity
0.16
Current ratio
5.98
Quick ratio
5.31
Net debt/EBITDA
1.03
Margins
EBITDA margin
-64.7%
Gross margin
35.8%
Net margin
-78.4%
Operating margin
-83.7%
Efficiency
Return on assets
-25.9%
Return on equity
-32%
Return on invested capital
-53.8%
Return on capital employed
-30.6%
Return on sales
-78%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TWST stock price

How has the Twist Bioscience stock price performed over time
Intraday
-1.52%
1 week
2.64%
1 month
14.01%
1 year
103.7%
YTD
7.54%
QTD
7.54%

Financial performance

How have Twist Bioscience's revenue and profit performed over time
Revenue
$262.36M
Gross profit
$93.89M
Operating income
-$219.51M
Net income
-$205.8M
Gross margin
35.8%
Net margin
-78.4%
TWST's revenue is up by 22% YoY and by 7% from the previous quarter
Twist Bioscience's net margin has increased by 21% YoY and by 6% from the previous quarter
Twist Bioscience's operating margin has increased by 19% YoY and by 6% QoQ
TWST's gross margin is down by 18% year-on-year and by 2.2% since the previous quarter

Growth

What is Twist Bioscience's growth rate over time

Valuation

What is Twist Bioscience stock price valuation
P/E
N/A
P/B
3.87
P/S
8.69
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.07
TWST's EPS is up by 6% year-on-year
TWST's P/B is 87% above its last 4 quarters average of 2.1 but 26% below its 5-year quarterly average of 5.3
Twist Bioscience's equity has decreased by 21% YoY and by 5% QoQ
TWST's P/S is 63% above its last 4 quarters average of 5.4 but 59% below its 5-year quarterly average of 21.7
TWST's revenue is up by 22% YoY and by 7% from the previous quarter

Efficiency

How efficient is Twist Bioscience business performance
TWST's return on sales is up by 21% year-on-year and by 6% since the previous quarter
The return on equity has declined by 20% year-on-year and by 7% since the previous quarter
The ROA has decreased by 17% YoY and by 6% from the previous quarter
Twist Bioscience's ROIC has decreased by 13% YoY and by 8% from the previous quarter

Dividends

What is TWST's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TWST.

Financial health

How did Twist Bioscience financials performed over time
Twist Bioscience's total assets has decreased by 19% YoY and by 6% QoQ
Twist Bioscience's total liabilities has decreased by 13% YoY and by 7% QoQ
Twist Bioscience's debt is 84% less than its equity
Twist Bioscience's debt to equity has increased by 23% YoY and by 7% QoQ
Twist Bioscience's equity has decreased by 21% YoY and by 5% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.